课题基金 / 基金详情

项目摘要

项目成果

YOSHIHIRO KAWAOKA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This comprehensive and highly integrated systems biology application seeks to delineate the complex host responses that determine the outcome of infections with potentially lethal viruses. To achieve this goal, cells and mice will be infected with wild-type and mutant influenza A, Ebola, and West Nile viruses to collect a variety of sample sets (these activities will be carried out by two Research Projects for influenza and Ebola or West Nile virus, respectively). A Technical Core will perform proteomics, phosphoproteomics, lipidomics, and metabolomics profiling, whereas mRNA and miRNA profiling will be out-sourced on a fee-for-service basis. In addition, multiple biological datasets, including virological data and data on protein-protein interactions, will be generated. All data will be analyzed by a Computational Modeling Core, which will integrate the diverse datasets and build predictive mechanistic and network models, including virtual lung and liver models. Based on these analyses, the two Research Projects will carry out comprehensive validation studies in vitro and in vivo (i.e., in knock-out mice). OMICs studies (as described above) from virus-infected knock-out and matched wild-type mice will be used for a second round of analysis, thereby achieving the systems biology paradigm of Iterative sampling, modeling, and validation. Storage, management, and exchange of the large and diverse datasets, and outreach to the community, will be facilitated by a Data Management and Resources Dissemination Core, whereas an Administrative Core will ensure that all administrative tasks are addressed. In summary, we propose a comprehensive and interactive systems biology program that will enhance predictive modeling of infectious disease and identify critical regulators of severe human virus pathogenicity that may be exploited for the development of therapeutic interventions.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/pathogens6020025
发表时间: 2017-06-10
期刊: Pathogens (Basel, Switzerland)
影响因子: --
作者: [Powell JD, Waters KM]
通讯作者: Waters KM
An Antiviral Role for TRIM14 in Ebola Virus Infection.
TRIM14 在埃博拉病毒感染中的抗病毒作用。
DOI: 10.1093/infdis/jiad325
发表时间: 2023
期刊: The Journal of infectious diseases
影响因子: --
作者: [Kuroda,Makoto, Halfmann,PeterJ, Thackray,LarissaB, Diamond,MichaelS, Feldmann,Heinz, Marzi,Andrea, Kawaoka,Yoshihiro]
通讯作者: Kawaoka,Yoshihiro
DOI: 10.1186/s12918-016-0336-6
发表时间: 2016-09-23
期刊: BMC systems biology
影响因子: --
作者: [McDermott JE, Mitchell HD, Gralinski LE, Eisfeld AJ, Josset L, Bankhead A 3rd, Neumann G, Tilton SC, Schäfer A, Li C, Fan S, McWeeney S, Baric RS, Katze MG, Waters KM]
通讯作者: Waters KM
A long-distance relationship: the commensal gut microbiota and systemic viruses.
远距离关系:共生肠道微生物群和系统性病毒。
DOI: 10.1016/j.coviro.2019.05.009
发表时间: 2019
期刊: Current opinion in virology
影响因子: 5.9
作者: [Winkler,EmmaS, Thackray,LarissaB]
通讯作者: Thackray,LarissaB
13
    Development of broadly-protective vaccines for influenza B viruses
    • 批准号:
      10821572
    • 项目类别:
    • 资助金额:
      $45.78万
    • 财政年份:
      2023
    • 负责人:
      YOSHIHIRO KAWAOKA
    • 依托单位:
    Development of broadly-protective vaccines for influenza B viruses
    • 批准号:
      10206685
    • 项目类别:
    • 资助金额:
      $22.78万
    • 财政年份:
      2021
    • 负责人:
      YOSHIHIRO KAWAOKA
    • 依托单位:
    Development of broadly-protective vaccines for influenza B viruses
    • 批准号:
      10359831
    • 项目类别:
    • 资助金额:
      $19.69万
    • 财政年份:
      2021
    • 负责人:
      YOSHIHIRO KAWAOKA
    • 依托单位:
    Immunological responses to pan-CoV vaccines
    • 批准号:
      10841734
    • 项目类别:
    • 资助金额:
      $155.82万
    • 财政年份:
      2021
    • 负责人:
      YOSHIHIRO KAWAOKA
    • 依托单位:
    海外基金